<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Certain primary transcripts of miRNA (pri-microRNAs) undergo <z:chebi fb="40" ids="33697">RNA</z:chebi> editing that converts <z:chebi fb="3" ids="16335">adenosine</z:chebi> to <z:chebi fb="0" ids="17596">inosine</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The Epstein-Barr virus (EBV) genome encodes multiple microRNA genes of its own </plain></SENT>
<SENT sid="2" pm="."><plain>Here we report that primary transcripts of ebv-miR-BART6 (pri-miR-BART6) are edited in latently EBV-infected cells </plain></SENT>
<SENT sid="3" pm="."><plain>Editing of <z:mp ids='MP_0002169'>wild-type</z:mp> pri-miR-BART6 <z:chebi fb="40" ids="33697">RNAs</z:chebi> dramatically reduced loading of miR-BART6-5p <z:chebi fb="40" ids="33697">RNAs</z:chebi> onto the microRNA-induced silencing complex </plain></SENT>
<SENT sid="4" pm="."><plain>Editing of a mutation-containing pri-miR-BART6 found in Daudi Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> C666-1 cell lines suppressed processing of miR-BART6 <z:chebi fb="40" ids="33697">RNAs</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Most importantly, miR-BART6-5p <z:chebi fb="40" ids="33697">RNAs</z:chebi> silence Dicer through multiple target sites located in the 3'-UTR of Dicer <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>The significance of miR-BART6 was further investigated in cells in various stages of latency </plain></SENT>
<SENT sid="7" pm="."><plain>We found that miR-BART6-5p <z:chebi fb="40" ids="33697">RNAs</z:chebi> suppress the EBNA2 <z:mp ids='MP_0001799'>viral</z:mp> oncogene required for transition from immunologically less responsive type I and type II latency to the more immunoreactive type III latency as well as Zta and Rta <z:mp ids='MP_0001799'>viral</z:mp> proteins essential for lytic replication, revealing the regulatory function of miR-BART6 in <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> and latency </plain></SENT>
<SENT sid="8" pm="."><plain>Mutation and A-to-I editing appear to be adaptive mechanisms that antagonize miR-BART6 activities </plain></SENT>
</text></document>